Circa Group AS (8U5.MU)

0.1130 0.0000 (0.00%) As of 08:10AM CEST. Market open.

Circa Group AS

Karenslyst Allé 53
Oslo 0279
Norway

https://www.circa-group.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Anthony James Duncan	Co-Founder & Director	456.76k	N/A	N/A
Mr. Bertel Evald Karlstedt	Chief Executive Officer	N/A	N/A	1962
Mr. Gregory R. Court	Co-Founder & Director	N/A	N/A	N/A
Mr. Erik Berger	Interim Chief Financial Officer	N/A	N/A	1963
Mr. Philipp Morgenthaler	Global Head of Manufacturing	N/A	N/A	N/A
Dr. Alessandro Napoli	VP Product Development	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Circa Group AS engages in producing bio-based chemicals in Australia, France, the United Kingdom, Belgium, and Norway. The company extracts value from non-food waste biomass to produce bio-based chemicals through its proprietary Furacell process. Its products include Cyrene, a polar aprotic solvent; and Levoglucosenone derivatives. Circa Group AS was founded in 2006 and is headquartered in Oslo, Norway.

Corporate Governance

Circa Group AS’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.